Capstone Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-86,498
Closed -$6.94M 1651
2016
Q4
$6.94M Buy
86,498
+2,896
+3% +$230K 0.2% 122
2016
Q3
$6.67M Buy
83,602
+2,986
+4% +$241K 0.19% 122
2016
Q2
$6.29M Buy
80,616
+2,704
+3% +$193K 0.19% 122
2016
Q1
$4.29M Buy
77,912
+1,359
+2% +$74K 0.12% 206
2015
Q4
$4.73M Buy
76,553
+3,093
+4% +$195K 0.14% 178
2015
Q3
$4.63M Sell
73,460
-3,039
-4% -$217K 0.14% 170
2015
Q2
$5.59M Buy
76,499
+2,201
+3% +$159K 0.16% 160
2015
Q1
$4.86M Buy
74,298
+1,651
+2% +$110K 0.14% 181
2014
Q4
$4.72M Buy
72,647
+240
+0.3% +$15.5K 0.14% 190
2014
Q3
$4.35M Buy
72,407
+231
+0.3% +$15.1K 0.15% 162
2014
Q2
$5M Buy
72,176
+46,398
+180% +$3.01M 0.16% 148
2014
Q1
$1.69M Sell
25,778
-3,650
-12% -$238K 0.05% 406
2013
Q4
$1.82M Sell
29,428
-13,471
-31% -$780K 0.05% 401
2013
Q3
$2.3M Sell
42,899
-1,039
-2% -$53.5K 0.06% 399
2013
Q2
$2M Buy
+43,938
New +$1.9M 0.05% 416

Other funds holding STJ

Capstone Asset Management's STJ Position: Q1 2017 in Review

Capstone Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 86,498 shares — an estimated $6.94M sold.

Capstone Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $6.94M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Capstone Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Capstone Asset Management sold 86,498 St Jude Medical shares in Q1 2017, an estimated $6.94M.
  • Capstone Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Capstone Asset Management's St Jude Medical position peaked at $6.94M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Capstone Asset Management's 13F filing for Q1 2017, filed 12 Apr 2017.